Literature DB >> 7090370

The menopause.

P F Brenner.   

Abstract

Hormone-replacement therapy for postmenopausal women has associated benefits and risks. The advantages of the administration of estrogen to postmenopausal women include preventing or reversing the atrophic changes of the genitourinary system, slowing of facial aging, relieving hot flushes and psychological symptoms, preventing atherosclerotic heart disease and retarding the development of osteoporosis. The disadvantages of the administration of estrogen to postmenopausal women include rare but serious clinical sequelae associated with the ingestion of the synthetic estrogen when it is one component of the combination oral contraceptives, increased risk of cancer developing in the estrogen-dependent organs and uterine bleeding. The benefits of long-term cyclic estrogen-gestagen therapy in preventing osteoporosis far outweigh the risks.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7090370      PMCID: PMC1273648     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  57 in total

1.  Reserpine and breast cancer in a retirement community.

Authors:  T M Mack; B E Henderson; V R Gerkins; M Arthur; J Baptista; M C Pike
Journal:  N Engl J Med       Date:  1975-06-26       Impact factor: 91.245

2.  An epidemiologic study of breast cancer.

Authors:  B E Henderson; D Powell; I Rosario; C Keys; R Hanisch; M Young; J Casagrande; V Gerkins; M C Pike
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

3.  Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood.

Authors:  H L Judd; G E Judd; W E Lucas; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

4.  Epidemiologic comparison of breast cancer patients with early and late onset of malignancy and general population controls.

Authors:  T J Craig; G W Comstock; P B Geiser
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

5.  Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age.

Authors:  D L Hemsell; J M Grodin; P F Brenner; P K Siiteri; P C MacDonald
Journal:  J Clin Endocrinol Metab       Date:  1974-03       Impact factor: 5.958

6.  Source of estrogen production in postmenopausal women.

Authors:  J M Grodin; P K Siiteri; P C MacDonald
Journal:  J Clin Endocrinol Metab       Date:  1973-02       Impact factor: 5.958

7.  Conversion of androstenedione to estrone by human tissue.

Authors:  A E Schindler; A Ebert; E Friedrich
Journal:  J Clin Endocrinol Metab       Date:  1972-10       Impact factor: 5.958

8.  Serum gonadotropin and steroid patterns during the normal menstrual cycle.

Authors:  D R Mishell; R M Nakamura; P G Crosignani; S Stone; K Kharma; Y Nagata; I H Thorneycroft
Journal:  Am J Obstet Gynecol       Date:  1971-09       Impact factor: 8.661

9.  Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis.

Authors:  H M Parrish; C A Carr; D G Hall; T M King
Journal:  Am J Obstet Gynecol       Date:  1967-09-15       Impact factor: 8.661

10.  Effect of sex hormones on bone in primary osteoporosis.

Authors:  B L Riggs; J Jowsey; P J Kelly; J D Jones; F T Maher
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.